![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Depomed, Inc. (delisted) | NASDAQ:DEPO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.30 | 7.25 | 7.43 | 0 | 01:00:00 |
As filed with the Securities and Exchange Commission on August 14, 2018
Registration No. 333-105994
Registration No. 333-101796
Registration No. 333-54982
Registration No. 333-85419
Registration No. 333-66923
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO
Form S-8 Registration Statement No. 333-105994
Form S-8 Registration Statement No. 333-101796
Form S-8 Registration Statement No. 333-54982
Form S-8 Registration Statement No. 333-85419
Form S-8 Registration Statement No. 333-66923
UNDER
THE SECURITIES ACT OF 1933
Depomed, Inc.
(Exact name of registrant as specified in its charter)
California |
|
94-3229046 |
(State or Other Jurisdiction
|
|
(I.R.S. Employer
|
7999 Gateway Blvd., Suite 300
Newark, California 94560
(Address of Principal Executive Offices)
Amended and Restated 1995 Stock Option Plan
(Full Titles of the Plans)
Arthur J. Higgins
President and Chief Executive Officer
7999 Gateway Blvd., Suite 300
Newark, California 94560
Telephone: (510) 744-8000
(Name, address, and telephone number, including area code, of agent for service)
Copy to:
Ryan A. Murr, Esq.
Gibson, Dunn & Crutcher LLP
555 Mission Street, Suite 3000
San Francisco, California 94105
Telephone: (415) 393-8373
Facsimile: (415) 374-8430
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
x |
Accelerated filer |
o |
|
|
|
|
Non-accelerated filer |
o (Do not check if a smaller reporting company) |
Smaller reporting company |
o |
|
|
|
|
Emerging growth company |
o |
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o
DEREGISTRATION OF SECURITIES
This Post-Effective Amendment, filed by Depomed, Inc., a California corporation (the Company), relates to the following Registration Statements on Form S-8 (collectively, the Registration Statements), filed with the Securities and Exchange Commission (the SEC) by the Company:
· Registration Statement No. 333-105994, filed with the SEC on June 10, 2003, pertaining to the registration of 1,800,000 shares of the Companys common stock issuable pursuant to the Depomed, Inc. Amended and Restated 1995 Stock Option Plan (the 1995 Plan).
· Registration Statement No. 333-101796, filed with the SEC on December 12, 2002, pertaining to the registration of 500,000 shares of the Companys common stock issuable pursuant to the 1995 Plan.
· Registration Statement No. 333-54982, filed with the SEC on February 5, 2001, pertaining to the registration of 600,000 shares of the Companys common stock issuable pursuant to the 1995 Plan.
· Registration Statement No. 333-85419, filed with the SEC on August 17, 1999, pertaining to the registration of 800,000 shares of the Companys common stock issuable pursuant to the 1995 Plan.
· Registration Statement No. 333-66923, filed with the SEC on November 6, 1998, pertaining to the registration of 1,000,000 shares of the Companys common stock issuable pursuant to the 1995 Plan.
No outstanding obligations exist under the 1995 Plan and the Company will not issue any common stock under the 1995 Plan. Consequently, the Company is filing this Post-Effective Amendment to these Registration Statements to withdraw and remove from registration, and hereby does withdraw and remove from registration, the registered but unissued securities issuable by the Company pursuant to the above-referenced Registration Statements.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Lake Forest, Illinois, on August 14, 2018.
|
|
Depomed, Inc. |
|
|
|
|
By: |
/s/ Amar Murugan |
|
|
Amar Murugan |
|
|
Senior Vice President and General Counsel |
* Pursuant to Rule 478 under the Securities Act of 1933, as amended, no other person is required to sign this Post-Effective Amendment.
1 Year Depomed, Inc. (delisted) Chart |
1 Month Depomed, Inc. (delisted) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions